Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination chemotherapy for hepatitis B virus: the path forward?

T Shaw1, S Locarnini

  • 1Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia. Tim.Shaw@mh.org.au

Drugs
|October 13, 2000
PubMed
Summary

Hepatitis B virus (HBV) infection remains a global health crisis, with current treatments facing challenges. Future HBV control hinges on developing new drugs and combination therapies to overcome drug resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fugue associated with migraine.

BMJ case reports·2025
Same author

A (Sub)field Guide to Quality Control in Hippocampal Subfield Segmentation on Highresolution T<sub>2</sub>-weighted MRI.

bioRxiv : the preprint server for biology·2023
Same author

Assessing the barriers and enablers to the implementation of the diagnostic radiographer musculoskeletal X-ray reporting service within the NHS in England: a systematic literature review.

BMC health services research·2023
Same author

Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

The European physical journal. C, Particles and fields·2022
Same author

Surgical techniques used in the management of intra-arachnoid diverticula in dogs across four referral centres and their immediate outcome.

The Journal of small animal practice·2022
Same author

Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

The European physical journal. C, Particles and fields·2021

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Hepatitis B virus (HBV) infection is a significant global health issue, causing approximately 1.2 million deaths annually.
  • Despite available vaccines and antiviral drugs, chronic HBV infection affects nearly 400 million people worldwide.
  • Current chemotherapy for chronic HBV infection has limitations, with no consistently successful strategies to date.

Purpose of the Study:

  • To review the current landscape of Hepatitis B virus (HBV) treatment and its challenges.
  • To discuss the impact of emerging anti-HBV drugs and the potential for drug resistance.
  • To explore the prospects of combination chemotherapy for effective HBV infection control.

Main Methods:

  • Review of existing literature on HBV infection, treatment, and drug development.

Related Experiment Videos

  • Analysis of the efficacy and limitations of current and novel anti-HBV therapies.
  • Discussion of strategies to mitigate drug resistance, drawing parallels with HIV treatment.

    • Main Results:

    • New anti-HBV drugs show rapid viral load reduction but are followed by slow residual virus elimination.
    • Drug resistance is emerging as a major obstacle to the long-term control of HBV infection.
    • Combination chemotherapy is a promising strategy to suppress or eliminate drug resistance.

    Conclusions:

    • While newer drugs improve HBV treatment, drug resistance poses a significant future challenge.
    • Combination chemotherapy, informed by basic research, is crucial for optimizing HBV treatment.
    • Continued development of novel anti-HBV drugs and combination regimens is essential for eventual HBV control.